Company news

Prothena Corporation plc news in 2026

Prothena Corporation plc's news releases, calls and decks from 2026, newest first.

View company

Prothena Reports Third Quarter 2026 Financial Results and Business Highlights

November 5, 2026

Prothena to Report Third Quarter 2026 Financial Results on November 5

October 29, 2026

Prothena to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

September 9, 2026

Prothena Reports Second Quarter 2026 Financial Results and Business Highlights

August 6, 2026

Prothena to Report Second Quarter 2026 Financial Results on August 6

July 30, 2026

Prothena Reports First Quarter 2026 Financial Results and Business Highlights

May 7, 2026

Prothena to Report First Quarter 2026 Financial Results on May 7

April 30, 2026

Prothena Announces Novo Nordisk Obtains Fast Track Designation from the U.S. FDA for Coramitug (PRX004) in ATTR Amyloidosis with Cardiomyopathy

April 27, 2026

Prothena Announces Leadership Team Updates

April 9, 2026

Prothena: Director's Report and Financial Statements for Fiscal Year 2025

March 27, 2026

Prothena Partners Present Data Supporting Next Generation Treatments for Parkinson’s and Alzheimer’s Disease at AD/PD™ 2026

March 20, 2026

Prothena Announces Achievement of $50 Million Clinical Milestone Payment from Novo Nordisk Related to Ongoing Phase 3 Clinical Trial for Coramitug (Formerly PRX004) in ATTR Amyloidosis with Cardiomyopathy

March 8, 2026

Prothena Announces up to $100 Million Share Repurchase Plan

February 26, 2026

Prothena Reports Fourth Quarter and Full Year 2025 Financial Results, and Provides Financial Guidance and Business Highlights

February 19, 2026

Prothena to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026

February 12, 2026

Calls in 2026

Decks in 2026